• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Individualized prediction nomograms for disease progression in mild COVID-19.个体化预测轻症 COVID-19 疾病进展的列线图。
J Med Virol. 2020 Oct;92(10):2074-2080. doi: 10.1002/jmv.25969. Epub 2020 May 17.
2
A nomogram for predicting mortality in patients with COVID-19 and solid tumors: a multicenter retrospective cohort study.用于预测 COVID-19 合并实体瘤患者死亡率的列线图:一项多中心回顾性队列研究。
J Immunother Cancer. 2020 Sep;8(2). doi: 10.1136/jitc-2020-001314.
3
Neutrophil to CD4+ lymphocyte ratio as a potential biomarker in predicting virus negative conversion time in COVID-19.中性粒细胞与 CD4+ 淋巴细胞比值作为预测 COVID-19 患者病毒阴转时间的潜在生物标志物。
Int Immunopharmacol. 2020 Aug;85:106683. doi: 10.1016/j.intimp.2020.106683. Epub 2020 Jun 6.
4
Early prediction and identification for severe patients during the pandemic of COVID-19: A severe COVID-19 risk model constructed by multivariate logistic regression analysis.在 COVID-19 大流行期间对重症患者进行早期预测和识别:采用多元逻辑回归分析构建的重症 COVID-19 风险模型。
J Glob Health. 2020 Dec;10(2):020510. doi: 10.7189/jogh.10.020510.
5
Early Prediction of Disease Progression in Patients with Severe COVID-19 Using C-Reactive Protein to Albumin Ratio.利用 C 反应蛋白与白蛋白比值对重症 COVID-19 患者的疾病进展进行早期预测。
Dis Markers. 2021 Dec 3;2021:6304189. doi: 10.1155/2021/6304189. eCollection 2021.
6
Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort.从中度到重度 2019 冠状病毒病进展的预测因素:一项回顾性队列研究。
Clin Microbiol Infect. 2020 Oct;26(10):1400-1405. doi: 10.1016/j.cmi.2020.06.033. Epub 2020 Jul 2.
7
Development and validation of a model for individualized prediction of hospitalization risk in 4,536 patients with COVID-19.开发和验证一种模型,用于对 4536 例 COVID-19 患者的住院风险进行个体化预测。
PLoS One. 2020 Aug 11;15(8):e0237419. doi: 10.1371/journal.pone.0237419. eCollection 2020.
8
[Logistic regression analysis of death risk factors of patients with severe and critical coronavirus disease 2019 and their predictive value].[新型冠状病毒肺炎重型、危重型患者死亡危险因素的Logistic回归分析及其预测价值]
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2020 May;32(5):544-547. doi: 10.3760/cma.j.cn121430-20200507-00364.
9
A nomogramic model based on clinical and laboratory parameters at admission for predicting the survival of COVID-19 patients.基于入院时临床和实验室参数的列线图模型预测 COVID-19 患者的生存。
BMC Infect Dis. 2020 Nov 30;20(1):899. doi: 10.1186/s12879-020-05614-2.
10
Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage.中性粒细胞与淋巴细胞比值可预测 2019 冠状病毒病重症患者的早期病情。
J Transl Med. 2020 May 20;18(1):206. doi: 10.1186/s12967-020-02374-0.

引用本文的文献

1
The Impacts of Nirmatrelvir-Ritonavir on Myocardial Injury and Long-Term Cardiovascular Outcomes in Hospitalized Patients with COVID-19 amid the Omicron Wave of the Pandemic.在新冠疫情奥密克戎浪潮期间,奈玛特韦-利托那韦对住院COVID-19患者心肌损伤和长期心血管结局的影响。
Cardiovasc Drugs Ther. 2024 Mar 11. doi: 10.1007/s10557-024-07570-4.
2
Regional moderate hyperthermia for mild-to-moderate COVID-19 (TherMoCoV study): a randomized controlled trial.局部适度热疗治疗轻至中度新型冠状病毒肺炎(TherMoCoV研究):一项随机对照试验
Front Med (Lausanne). 2023 Dec 22;10:1256197. doi: 10.3389/fmed.2023.1256197. eCollection 2023.
3
Validation of a risk prediction model for COVID-19: the PERIL prospective cohort study.新型冠状病毒肺炎风险预测模型的验证:PERIL前瞻性队列研究
Future Virol. 2023 Oct. doi: 10.2217/fvl-2023-0036. Epub 2023 Nov 7.
4
Development and external validation of the DOAT and DOATS scores: simple decision support tools to identify disease progression among nonelderly patients with mild/moderate COVID-19.DOAT 和 DOATS 评分的制定与外部验证:用于识别轻症/中度 COVID-19 非老年患者疾病进展的简单决策支持工具。
BMC Pulm Med. 2023 Aug 28;23(1):312. doi: 10.1186/s12890-023-02604-3.
5
Mixed storm in SARS-CoV-2 infection: A narrative review and new term in the Covid-19 era.SARS-CoV-2 感染中的混合性炎症风暴:Covid-19 时代的叙述性综述和新术语。
Immun Inflamm Dis. 2023 Apr;11(4):e838. doi: 10.1002/iid3.838.
6
Diagnostic Values of Laboratory Biomarkers in Predicting a Severe Course of COVID-19 on Hospital Admission.入院时实验室生物标志物对预测 COVID-19 严重病程的诊断价值。
Biomed Res Int. 2022 Nov 7;2022:5644956. doi: 10.1155/2022/5644956. eCollection 2022.
7
Validation of the RIM Score-COVID in the Spanish SEMI-COVID-19 Registry.验证 RIM 评分-COVID 在西班牙 SEMI-COVID-19 登记处的应用。
Intern Emerg Med. 2023 Apr;18(3):907-915. doi: 10.1007/s11739-023-03200-3. Epub 2023 Jan 21.
8
Clinical and laboratory predictors for disease progression in patients with COVID-19: A multi-center cohort study.临床和实验室预测因素对 COVID-19 患者疾病进展的影响:一项多中心队列研究。
Biomed J. 2023 Feb;46(1):100-109. doi: 10.1016/j.bj.2022.11.002. Epub 2022 Nov 19.
9
Haematological Traits in Symptomatic and Asymptomatic COVID-19 Positive Patients for Predicting Severity and Hospitalization.有症状和无症状新冠病毒检测呈阳性患者的血液学特征对预测病情严重程度和住院情况的作用
J Blood Med. 2022 Aug 27;13:447-459. doi: 10.2147/JBM.S365218. eCollection 2022.
10
Predicting respiratory failure for COVID-19 patients in Japan: a simple clinical score for evaluating the need for hospitalisation.预测日本 COVID-19 患者的呼吸衰竭:一种简单的临床评分,用于评估住院需求。
Epidemiol Infect. 2021 Jul 30;149:e175. doi: 10.1017/S0950268821001837.

本文引用的文献

1
The viral, epidemiologic, clinical characteristics and potential therapy options for COVID-19: a review.新型冠状病毒肺炎的病毒学、流行病学、临床特征及潜在治疗选择的研究进展。
Eur Rev Med Pharmacol Sci. 2020 Apr;24(8):4576-4584. doi: 10.26355/eurrev_202004_21044.
2
Projecting the demand for ventilators at the peak of the COVID-19 outbreak in the USA.预测美国新冠疫情爆发高峰期对呼吸机的需求。
Lancet Infect Dis. 2020 Oct;20(10):1123-1125. doi: 10.1016/S1473-3099(20)30315-7. Epub 2020 Apr 21.
3
Use of non-invasive ventilation for patients with COVID-19: a cause for concern?新型冠状病毒肺炎患者使用无创通气:值得关注吗?
Lancet Respir Med. 2020 Jun;8(6):e45. doi: 10.1016/S2213-2600(20)30181-8. Epub 2020 Apr 21.
4
Epidemiological trends of COVID-19 epidemic in Italy over March 2020: From 1000 to 100 000 cases.2020 年 3 月意大利 COVID-19 疫情的流行病学趋势:从 1000 例到 100000 例。
J Med Virol. 2020 Oct;92(10):1956-1961. doi: 10.1002/jmv.25908. Epub 2020 May 12.
5
The diagnostic and predictive role of NLR, d-NLR and PLR in COVID-19 patients.中性粒细胞与淋巴细胞比值、动态中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在 COVID-19 患者中的诊断及预测作用。
Int Immunopharmacol. 2020 Jul;84:106504. doi: 10.1016/j.intimp.2020.106504. Epub 2020 Apr 13.
6
The impact of COPD and smoking history on the severity of COVID-19: A systemic review and meta-analysis.COPD 和吸烟史对 COVID-19 严重程度的影响:系统评价和荟萃分析。
J Med Virol. 2020 Oct;92(10):1915-1921. doi: 10.1002/jmv.25889. Epub 2020 May 17.
7
Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19.中性粒细胞与淋巴细胞比值可作为 COVID-19 住院患者死亡的独立危险因素。
J Infect. 2020 Jul;81(1):e6-e12. doi: 10.1016/j.jinf.2020.04.002. Epub 2020 Apr 10.
8
COVID-19 and Liver Dysfunction: Current Insights and Emergent Therapeutic Strategies.新型冠状病毒肺炎与肝功能障碍:当前见解及新出现的治疗策略
J Clin Transl Hepatol. 2020 Mar 28;8(1):18-24. doi: 10.14218/JCTH.2020.00018. Epub 2020 Mar 30.
9
Prediction for Progression Risk in Patients With COVID-19 Pneumonia: The CALL Score.COVID-19 肺炎患者进展风险预测:CALL 评分。
Clin Infect Dis. 2020 Sep 12;71(6):1393-1399. doi: 10.1093/cid/ciaa414.
10
Prediction models for diagnosis and prognosis of covid-19: systematic review and critical appraisal.COVID-19 诊断和预后预测模型:系统评价和批判性评估。
BMJ. 2020 Apr 7;369:m1328. doi: 10.1136/bmj.m1328.

个体化预测轻症 COVID-19 疾病进展的列线图。

Individualized prediction nomograms for disease progression in mild COVID-19.

机构信息

Department of Liver Research Center, The First Affiliated Hospital of Fujian Medical University, Fuzhou, China.

Department of Critical Care, The Third People's Hospital of Yichang, China.

出版信息

J Med Virol. 2020 Oct;92(10):2074-2080. doi: 10.1002/jmv.25969. Epub 2020 May 17.

DOI:10.1002/jmv.25969
PMID:32369205
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7267495/
Abstract

The coronavirus disease 2019 (COVID-19) has evolved into a pandemic rapidly. The majority of COVID-19 patients are with mild syndromes. This study aimed to develop models for predicting disease progression in mild cases. The risk factors for the requirement of oxygen support in mild COVID-19 were explored using multivariate logistic regression. Nomogram as visualization of the models was developed using R software. A total of 344 patients with mild COVID-19 were included in the final analysis, 45 of whom progressed and needed high-flow oxygen therapy or mechanical ventilation after admission. There were 188 (54.7%) males, and the average age of the cohort was 52.9  ± 16.8 years. When the laboratory data were not included in multivariate analysis, diabetes, coronary heart disease, T   ≥  38.5℃ and sputum were independent risk factors of progressive COVID-19 (Model 1). When the blood routine test was included the CHD, T ≥ 38.5℃ and neutrophil-to-lymphocyte ratio were found to be independent predictors (Model 2). The area under the receiver operator characteristic curve of model 2 was larger than model 1 (0.872 vs 0.849, P = .023). The negative predictive value of both models was greater than 96%, indicating they could serve as simple tools for ruling out the possibility of disease progression. In conclusion, two models comprised common symptoms (fever and sputum), underlying diseases (diabetes and coronary heart disease) and blood routine test are developed for predicting the future requirement of oxygen support in mild COVID-19 cases.

摘要

新型冠状病毒病(COVID-19)迅速演变为大流行。大多数 COVID-19 患者为轻症。本研究旨在建立预测轻症患者疾病进展的模型。采用多变量逻辑回归探讨轻度 COVID-19 需要氧支持的危险因素。使用 R 软件开发了用于可视化模型的列线图。共纳入 344 例轻症 COVID-19 患者,其中 45 例在入院后进展并需要高流量氧疗或机械通气。男性 188 例(54.7%),队列平均年龄为 52.9±16.8 岁。当实验室数据未纳入多变量分析时,糖尿病、冠心病、T≥38.5℃和咳痰是 COVID-19 进展的独立危险因素(模型 1)。当纳入血常规检查时,CHD、T≥38.5℃和中性粒细胞与淋巴细胞比值被发现是独立预测因素(模型 2)。模型 2 的受试者工作特征曲线下面积大于模型 1(0.872 比 0.849,P=0.023)。两个模型的阴性预测值均大于 96%,表明它们可作为排除疾病进展可能性的简单工具。总之,建立了两个模型,包括常见症状(发热和咳痰)、基础疾病(糖尿病和冠心病)和血常规检查,用于预测轻度 COVID-19 患者未来对氧支持的需求。